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Introduction
Although renal transplantation represents a choice treat-
ment for patients with end-stage renal disease (ESRD),
long-term survival of pediatric renal transplant recipients
is still lower than in the general population [1]. Renal
transplant recipients, in common with other patients with
varying degrees of renal failure, have an increased risk of
cardiovascular disease (CVD) development [2]. Abnor-
malities in lipid homeostasis, as the main risk factors for
CVD, are frequently seen in such category of patients [3].
Numerous studies have demonstrated that the quality of
high-density lipoprotein (HDL) and low-density lipopro-
tein (LDL) particles, rather than simply the levels of
HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C),
exert a potent influence on CVD risk [4,5]. Indeed, both
small, dense LDL (sdLDL) and small-sized HDL particles
have emerged as novel CVD risk factors [6]. So far, heter-
ogeneity of LDL and HDL particles has been studied less
extensively in pediatric renal transplant recipients.
Early atherosclerotic lesions in asymptomatic individu-
als are commonly assessed by measuring the intima-
media thickness (IMT) of the affected vessel. This method
is widely used for carotid arteries and increased carotid
Keywords
early atherosclerosis, carotid intima-media
thickness, immunosuppressive therapy,




Aleksandra Zeljkovic, Department of Medical
Biochemistry, Faculty of Pharmacy, University
of Belgrade, Vojvode Stepe 450, P. Box 146;
11000 Belgrade, Serbia. Tel.: +381 11 3951
284; fax: +381 11 39 72 840 or +381 11 39




Received: 25 February 2011
Revision requested: 7 April 2011
Accepted: 15 July 2011
Published online: 12 August 2011
doi:10.1111/j.1432-2277.2011.01313.x
Summary
Renal transplant recipients often suffer from dyslipidemia which is one of the
principal risk factors for cardiovascular disease. This study sought to determine
characteristics of high-density lipoprotein (HDL) and low-density lipoprotein
(LDL) particles and their associations with carotid intima-media thickness
(cIMT) in a group of pediatric renal transplant recipients. We also examined
the influence of immunosuppressive therapy on measured LDL and HDL parti-
cle characteristics. HDL size and subclass distribution were determined using
gradient gel electrophoresis, while concentrations of small, dense LDL
(sdLDL)-cholesterol (sdLDL-C) and sdLDL-apolipoprotein B (sdLDL-apoB)
using heparin-magnesium precipitation method in 21 renal transplant recipi-
ents and 32 controls. Renal transplant recipients had less HDL 2b (P < 0.001),
but more HDL 3a (P < 0.01) and 3b (P < 0.001) subclasses. They also had
increased sdLDL-C (P < 0.01) and sdLDL-apoB (P < 0.05) levels. The propor-
tion of the HDL 3b subclasses was a significant predictor of increased cIMT
(P < 0.05). Patients treated with cyclosporine had significantly higher sdLDL-C
and sdLDL-apoB concentrations (P < 0.05) when compared with those on
tacrolimus therapy. Pediatric renal transplant recipients have impaired distribu-
tion of HDL and LDL particles. Changes in the proportion of small-sized HDL
particles are significantly associated with cIMT. Advanced lipid testing might
be useful in evaluating the effects of immunosuppressive therapy.
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IMT (cIMT) predicts the risk of developing myocardial
infarction and stroke in the general population [7], as
well as in ESRD patients [8]. In addition, studies in the
pediatric population have revealed significant associations
between cIMT and traditional CVD risk factors [9]. How-
ever, the possible contribution of sdLDL and small-sized
HDL, beyond traditional risk factors, to increased cIMT
in renal transplant recipients remains to be elucidated.
Significant sources of post-transplant dyslipidemia in
both adults and children are side effects of immunosup-
pressive medications. It has been shown that cyclosporine
administration is more likely associated with dyslipidemia
than the use of tacrolimus [10]. However, the impact of
particular immunosuppressive drugs on HDL and LDL
particle characteristics has been scarcely investigated.
The aim of this study was to evaluate HDL and LDL
particle characteristics in a group of pediatric renal trans-
plant recipients. In addition, we have examined their rela-
tionship with cIMT and have evaluated the effects of
cyclosporine and tacrolimus immunosuppressive therapy
on measured LDL and HDL particle characteristics.
Patients and methods
Subjects
The study group consisted of 21 adolescent patients who
underwent renal transplantation during childhood (13
male and eight female; mean age 15.00 ± 3.21 years;
range 9–21). All the patients were recruited in the
Nephrology Department at the University Children’s Hos-
pital in Belgrade, where they were treated. Underlying
renal diseases included: congenital abnormalities of the
kidney and urinary tract (n = 11), polycystic kidney dis-
ease (n = 4), Jeune’s syndrome (n = 1), irreversible tubu-
lar necrosis (n = 1), Joubert syndrome (n = 1), focal
segmental glomerulosclerosis (n = 1), hemolytic uremic
syndrome (n = 1), and diffuse mesangial sclerosis
(n = 1). Exclusion criteria included primary cardiac dis-
ease, diabetes mellitus and any co-morbid condition, such
as infectious disease or acute transplant rejection at the
time of enrollment. At the point of study entry, height
and weight [for body mass index (BMI) calculation] and
blood pressure were measured. Clinical characteristics of
our study group are listed in Table 1.
Regarding current medical treatment, 17 patients
were receiving triple immunosuppressant therapy
(prednisone/tacrolimus/mycophenolate mofetil, n = 7;
prednisone/cyclosporine/mycophenolate mofetil, n = 5;
prednisone/sirolimus/mycophenolate mofetil, n = 1; pred-
nisone/cyclosporine/azathioprine, n = 3; prednisone/ta-
crolimus/azathioprine, n = 1). One patient was on
prednisone/cyclosporine combination therapy and three
patients received quadruple immunosuppressant therapy
(prednisone/sirolimus/tacrolimus/mycophenolate mofetil).
Sixteen patients were receiving antihypertensive therapy,
while no subjects received hypolipemic agents. The con-
trol group was selected from a preliminary pool of 124
healthy adolescents (59 males and 65 females, aged from
11 to 18 years) who were recruited in various health
centers in Belgrade during regular annual medical check-
ups and were free of any acute or chronic pathological
condition. The final selection of the control group
included in this study was accomplished by matching:
age, male/female proportion and BMI values with the
patients. As a result, 32 age-, gender- and BMI-matched
healthy normotensive adolescents formed the control
group. None of the subjects in this group used any pre-
scribed medications. Both patients and controls were Ser-
bian Caucasians. Informed consent was obtained from
each subject enrolled in the study, or in the case of min-
ors, from a parent or tutor. The whole study was planned
and executed following the ethical guidelines of the Hel-
sinki Declaration. According to institutional guidelines,
the Ethics Committee at the Faculty of Pharmacy, Univer-
sity of Belgrade approved the whole study protocol.
Carotid intima-media thickness (cIMT) measurement
A single sonographer who was specifically trained to carry
out the prescribed study examination performed the IMT
measurement. The sonographer was uninformed and
unfamiliar with the patient’s diagnosis, therapy and labo-
ratory findings. All the measurements were achieved in a
standard fashion with patients in the supine position and
their head turned slightly to the contralateral side. Images
were taken from longitudinal views of the far wall of left
and right common carotid arteries, bifurcation and inter-
Table 1. Clinical characteristics of renal transplant recipients.
Renal transplant
recipients; n = 21
Age (years) 15.00 ± 3.21
Gender, male (%) 61.9
BMI (kg/m2) 20.23 ± 3.58
Systolic blood pressure (mmHg) 119.25 ± 12.06
Diastolic blood pressure (mmHg) 76.50 ± 8.90
cIMT (mm) 0.41 ± 0.09
Duration of chronic kidney disease (years) 11.05 ± 5.61
Hemodialysis prior transplantation (%) 77.3
Hemodialysis duration (months) 4.44 ± 3.32
Post-transplantation interval (years)* 4 (1–5)
Creatinine clearance (ml/min) 84.65 ± 32.56
BMI, body mass index; cIMT, carotid intima-media thickness.
Continuous variables are presented as mean ± standard deviation,
whereas categorical variables are presented as relative frequencies.
*Numeric value is presented as median and interquartile range.
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nal carotid arteries at the bulb level. Each artery was ana-
lyzed from proximal to distal and a measurement was per-
formed 10 mm below the carotid bifurcation in common
carotid arteries, at the bifurcation level and 10 mm after
the carotid bifurcation in the internal carotid arteries.
IMT was defined as the distance from the leading edge of
the lumen–intima interface to the leading edge of the
media–adventitia interface of the far wall. The IMT repre-
sents the mean values of both sides. All the results were
achieved on a single ultrasound machine Siemens ACU-
SON Antares, using a linear array 7 MHz scan head with
standardized image settings, including resolution mode,
depth of field, gain and transmission focus. The measure-
ments were performed semi-automatically using a software
enhancement for IMT measurement (AHP-Arterial Health
Package Siemens Software). After placing the ECG elec-
trodes and starting the program recordings were triggered
at the end of the diastolic cycle. Following image acquisi-
tion and starting the calculating option, IMT was calcu-
lated and printed. The data were archived on hard disk
until the end of the study. The overall coefficient of varia-
tion for repeated measures of cIMT was <4%.
Biochemical analyses
Blood samples were collected into evacuated tubes con-
taining EDTA and serum sample tubes after a 12-hour
fasting period. Plasma and serum were separated by
immediate centrifugation at 1500 · g for 10 min at 4 C.
Aliquots of each sample were stored at )80 C. The sam-
ples were thawed immediately before analyses.
Serum urea, creatinine, total protein, albumin, and
hemoglobin concentrations were measured by routine lab-
oratory methods. Glomerular filtration rate was assessed
by measuring 24-h creatinine clearance. Serum total cho-
lesterol (TC), free cholesterol (FC) and triglyceride (TG)
concentrations were assayed using enzymatic methods
using an ILab 600 analyzer (Instrumentation Laboratory,
Lexington, MA, USA). The concentration of HDL-C was
measured using the same enzymatic method after precipi-
tation of the plasma with phosphotungstic acid in the
presence of magnesium ions. The concentration of LDL-C
was determined using a direct homogeneous assay (Olym-
pus Diagnostica GmbH, Hamburg, Germany). Apolipo-
protein A-I (apoA-I) and apolipoprotein B (apoB) were
measured using immunoturbidimetric assays (Dialab,
Vienna, Austria).
HDL particle size and subclass determination
Plasma HDL particles were separated using a method pre-
viously described by Rainwater et al. [11]. Composite
(3–31%) polyacrylamide gradient gels were used for elec-
trophoretic separations of HDL subfractions. A detailed
description of the procedure has been published elsewhere
[12,13]. In brief, electrophoresis was performed at 8 C in
a Hoefer SE 600 Ruby electrophoresis unit (Amersham
Pharmacia Biotech, Vienna, Austria) using Tris (90 mm)-
boric acid (80 mm)-Na2EDTA (2.7 mm) buffer, pH 8.35
for 20 h. Gels were calibrated using the Pharmacia High
Molecular Weight protein standards and carboxylated
polystyrene microsphere beads. After electrophoretic sepa-
ration, the gels were stained for proteins with Coomassie
brilliant blue G-250 and for lipids with Sudan black. Gels
were analyzed using Image Scanner (Amersham Pharmacia
Biotech, Vienna, Austria) with Image Quant software
(version 5.2;1999; Molecular Dynamics, Sunnyvale, CA,
USA). The migration distance for each absorbance peak
was determined and the particle diameter corresponding to
each peak was calculated from the calibration curve. The
estimated diameter of the major peak in HDL region of
each scan was referred to as the dominant particle diameter.
The relative content of each HDL subclass was estimated by
determining the areas under the peaks of densitometric
scan of the sample, as previously reported [12,13].
LDL particle characterization
Low-density lipoprotein particles characterization was
achieved by measuring concentrations of cholesterol and
apoB within the sdLDL fraction (sdLDL-C and sdLDL-
apoB, respectively) using the heparin-magnesium precipi-
tation method [14,15]. In brief, a serum sample (150 ll)
was mixed with precipitation reagent (150 ll) containing
150 U/ml of heparin sodium salt and 90 mmol/l MgCl2,
incubated for 10 min at 37 C, placed in an ice bath for
15 min and centrifuged at 15000 rpm for 15 min at 4 C.
An aliquot of the supernatant was used to measure LDL-
C and apoB concentrations. The proportions of sdLDL-C
and sdLDL-apoB in total LDL-C and LDL-apoB, respec-
tively, were calculated as (sdLDL-C/serum LDL-C) · 100
and (sdLDL-apoB/serum apoB) · 100 and expressed in
percents.
Lecithin:cholesterol acyltransferase (LCAT) and cholesteryl
ester transfer protein (CETP) activities measurement
Lecithin:cholesterol acyltransferase (LCAT) and choleste-
ryl ester transfer protein (CETP) activities were deter-
mined by following a previously described method
[16–18]. In principle, LCAT activity was determined as a
function of the decrease in the amount of FC in plasma
after 3 h of incubation at 37 C. CETP activity was
assessed as the rate of cholesterol esters (CE) transfer
from HDL to VLDL and LDL as a function of time. CE
mass transfer was measured as the difference between the
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rate of decrease in FC in the whole plasma and the rate
of increase of CE in HDL during 3 h of incubation at
37 C. Accordingly, molar LCAT activity was calculated
as initial plasma FC ) final plasma FC, while CETP activ-
ity as: (initial plasma FC ) final plasma FC) ) [(final
HDL-TC ) final HDL-FC) ) (initial HDL-TC ) initial
HDL-FC)]. All assays were performed in duplicate.
Statistical analysis
Differences in continuous variables between the groups
were analyzed using the Student’s t-test for normally dis-
tributed variables. As the distributions of TG, LCAT,
CETP, sdLDL-C, sdLDL-apoB, % sdLDL-C, and %
sdLDL-apoB were skewed, the data are presented as
median (interquartile range) and compared using the
Mann–Whitney U-test. Group differences for categorical
variables were examined using the chi-squared test.
Univariate associations were evaluated using Spearman’s
correlation analysis. Subsequent stepwise multiple regres-
sion analysis was used to estimate the contribution of
independent predictors to the variance in cIMT. Differ-
ences with P < 0.05 were considered to be statistically sig-
nificant. All calculations were performed using MedCalc
software.
Results
To determine differences in serum lipids and lipoproteins,
we compared the renal transplant recipients group with an
age-, gender-, and BMI-matched control group of healthy
children. The patients had significantly higher TC, TG, and
apoB concentrations. Plasma CETP activity was signifi-
cantly higher in patients than in controls. No differences in
LCAT activity were seen between the two groups. Regarding
differences in renal function parameters, the concentrations
of creatinine and urea were higher and the concentration of
albumin was lower in the patients (Table 2).
To gain further insight into the characteristics of lipo-
protein particles, we analyzed HDL subclass distributions
in patients and controls (Fig. 1). Our results indicated that
patients had a significantly lower relative proportion of the
large HDL 2b subclass in addition to a significant increase
in the proportions of small HDL 3a and 3b subclasses.
The differences between patients and controls in
sdLDL-C, sdLDL-apoB, sdLDL-C (%), and sdLDL-apoB
(%) are shown in Fig. 2. Renal transplant recipients had
higher concentrations of sdLDL-C and sdLDL-apoB, as
well as higher sdLDL-C (%).
We next analyzed correlations between serum lipids,
lipoproteins, and parameters of renal function with the
measured characteristics of HDL and LDL particles in the
patients (Table 3). Our results revealed significant positive
correlation of HDL diameter with HDL-C, while negative
correlation was found with TG concentration. The rela-
tive proportion of HDL 2b correlated positively, while the
proportions of HDL 3a and 3b correlated negatively with
HDL-C and apoA-I concentrations. Regarding the rela-
tionship with parameters of renal function and other
recorded characteristics of patients, we found that the
duration of chronic kidney disease correlated negatively
with the proportion of HDL 2b and positively with the
proportion of HDL 3a.
We also found significant positive correlations between
TG concentration and sdLDL-C, sdLDL-apoB, and
sdLDL-C (%). Serum apoB levels correlated positively
with sdLDL-C. The measured characteristics of LDL parti-
cles showed no correlations with the examined parameters
of renal functions.
Possible associations between different features of HDL
and LDL particles were next examined. The results
showed significant negative correlations of HDL diameter
with sdLDL-C and sdLDL-C (%).
Table 2. Clinical characteristics, renal function parameters, and lipid
and lipoprotein parameters in renal transplant recipients and control
group.
Renal transplant
recipients; n = 21
Controls;
n = 32 P
Age (years) 15.00 ± 3.21 14.06 ± 1.25 0.140
Gender, male (%) 61.9 59.4 0.854
BMI (kg/m2) 20.23 ± 3.58 20.21 ± 4.09 0.986
Systolic blood pressure
(mmHg)
119.25 ± 12.06 114.22 ± 9.85 0.107
Diastolic blood pressure
(mmHg)
76.50 ± 8.90 73.44 ± 6.89 0.192
Hemoglobin (g/l) 124.53 ± 15.82 130.66 ± 11.11 0.120
Creatinine (lmol/l) 95.43 ± 33.62 23.19 ± 5.46 <0.001
Urea (mmol/l) 7.51 ± 2.40 4.23 ± 1.74 <0.001
Total proteins (g/l) 68.48 ± 5.53 70.59 ± 4.83 0.146
Albumin (g/l) 44.50 ± 2.43 50.49 ± 5.86 <0.001
TC (mmol/l) 5.00 ± 0.99 4.46 ± 0.82 <0.05
LDL-C (mmol/) 2.87 ± 0.89 2.85 ± 0.81 0.943
HDL-C (mmol/l) 1.36 ± 0.51 1.30 ± 0.24 0.578
ApoA-I (g/l) 1.65 ± 0.42 1.75 ± 0.26 0.359
ApoB (g/l) 1.01 ± 0.26 0.84 ± 0.21 <0.01
TG (mmol/l)* 1.61 (0.84–2.27) 0.64 (0.50–0.77) <0.001
Dominant HDL particle
diameter (nm)
10.64 ± 0.78 10.76 ± 0.80 0.574
LCAT activity (lmol/l/h)* 24.5 (18.8–37.6) 19.6 (13.5–25.9) 0.110
CETP activity (lmol/l/h)* 27.4 (20.3–37.7) 15.9 (11.1–28.4) <0.05
BMI, body mass index; TC, total cholesterol; LDL-C, low-density lipopro-
tein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; ApoA-I,
apolipoprotein A-I; ApoB, apolipoprotein B; TG, triglyceride; LCAT, leci-
thin:cholesterol acyltransferase; CETP, cholesteryl ester transfer protein.
Variables are presented as mean ± standard deviation and compared
using the Student’s t-test.
*Values are presented as median (interquartile range) and compared
using the Mann–Whitney U-test.
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As we aimed to explore the associations between both
HDL and LDL particle characteristics with development
of CVD in renal transplant recipients, we used cIMT as
a marker of early, subclinical atherosclerosis. Univariate
correlation analysis showed that cIMT correlated with
age, concentration of TG, HDL diameter, and relative
Figure 1 High-density lipoprotein subclass distribution in renal transplant recipients and controls. (a) Electrophoretic patterns of HDL subclasses
(lanes 1–7: patients, lanes 8–13: controls); (b) Relative proportions of HDL subclasses in patients and controls. *P < 0.05; **P < 0.01;
***P < 0.001. HDL, high-density lipoprotein.
Figure 2 Concentrations of sdLDL-C
and sdLDL-apoB in renal transplant
recipients and controls. Lower and
upper lines indicate the 10th and 90th
percentiles. The box indicates the 25th
and 75th percentiles, while the line in
the box indicates the median value.
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proportion of HDL 3b. To reveal significant and inde-
pendent determinants of cIMT, we performed multiple
linear regression analysis (Table 4). When age, gender,
BMI, and examined lipid and lipoprotein parameters
were included in Model 1, only the relative proportion
of HDL 3b was a significant predictor of cIMT. After
addition of renal disease markers, duration of chronic
kidney disease, hemodialysis prior to transplantation,
post-transplantation interval, and blood pressure in
Model 2, the proportion of HDL 3b retained its signifi-
cance.
Lastly, we analyzed the impact of administration of dif-
ferent immunosuppressants on HDL and LDL particle
characteristics. Patients receiving cyclosporine therapy
(n = 9) had a significantly higher sdLDL-C and sdLDL-
apoB concentrations when compared with patients on
tacrolimus therapy (n = 12) (Fig. 3). Similar unfavorable
changes were also seen for other LDL and HDL particle
characteristics. The relative proportion of HDL 2b was
lower (46.9 ± 4.3% vs. 49.6 ± 4.9%), while the relative
proportions of HDL 3a (14.4 ± 2.5% vs. 13.6 ± 1.9%),
HDL 3b (7.7 ± 1.5% vs. 7.4 ± 1.5%), and HDL 3c
(7.3 ± 1.1% vs. 7.1 ± 1.8%) were higher in patients trea-
ted with cyclosporine when compared with the tacroli-
mus-receiving patient group. However, none of the
observed differences reached statistical significance.
Discussion
Dyslipidemia is recognized as one of the principal CVD
risk factors in renal transplant recipients. In this study,
we have observed a significant shift in HDL particle dis-
tribution toward smaller subclasses (Fig. 1) in pediatric
renal transplant recipients, despite the fact that we found
no differences in the dominant HDL diameter and HDL-
C level between patients and controls (Table 2). Likewise,
sdLDL-C and sdLDL-C (%) were higher in renal trans-
plant recipients (Fig. 2), although serum LDL-C levels
were not different when compared with controls. In the
study by Siirtola et al. [19], unfavorable changes in serum
levels of TC, LDL-C, and HDL-C were less prevalent and
less severe in pediatric renal transplant recipients when
compared with reports in adults. Correspondingly, we
found that apart from TC, TG, and apoB concentrations,
other traditional lipid measurements did not differ
between our two examined groups (Table 2). Therefore,
Table 3. Correlations between serum lipids, lipoproteins, and parameters of renal function with the measured characteristics of HDL and LDL par-























HDL-C (mmol/l) 0.485* 0.617** )0.257 )0.622** )0.567** )0.301 )0.373 )0.371 )0.370 )0.309
apoA-I (g/l) 0.350 0.441* 0.112 )0.494* )0.621** )0.212 )0.220 )0.419 )0.263 )0.330
ApoB (g/l) )0.105 )0.232 )0.135 0.137 )0.009 0.040 0.633** )0.058 0.419 )0.379
TG (mmol/l) )0.574** )0.291 0.176 0.406 0.238 0.102 0.733** 0.625** 0.607** 0.360
HDL diameter (nm) ) 0.477* 0.257 )0.478* )0.254 0.054 )0.452* )0.485* )0.378 )0.350
Duration of chronic
kidney disease (years)
)0.153 )0.537* 0.093 0.483* 0.350 0.296 0.405 0.242 0.343 0.037
HDL, high-density lipoprotein; sdLDL-C, small, dense low-density lipoprotein-cholesterol; sdLDL-apoB, small, dense low-density lipoprotein-apolipo-
protein B; ApoA-I, apolipoprotein A-I; TG, triglyceride.
*P < 0.05; **P < 0.01.
Table 4. Univariate and stepwise multiple linear regression analysis
for cIMT in renal transplant recipients.
Parameters R P
Univariate analysis
Age (years) 0.554 <0.05
TG (mmol/l) 0.538 <0.05
HDL diameter (nm) )0.591 <0.05
HDL 3b (%) 0.613 <0.05
Model Predictors b (SE b) P
Adjusted R2
for model
Multiple linear regression analysis
Model 1* HDL 3b (%) 0.600 (0.016) <0.05 0.302




cIMT, carotid intima-media thickness; TG, triglyceride; HDL, high-
density lipoprotein.
*Variables included in the model were: age, gender (0-woman,
1-man), BMI, TC, HDL-C, LDL-C, TG, apoA-I, apoB, sdLDL-C, sdLDL-
apoB, dominant HDL diameter, HDL subclasses.
†Variables included in the model were as follows: systolic blood pres-
sure, diastolic blood pressure, duration of chronic kidney disease,
post-transplantation interval, hemodialysis prior transplantation (0-no,
1-yes), creatinine clearance, serum creatinine concentration, serum
urea concentration, hemoglobin concentration and all variables from
Model 1.
Values are given as correlation coefficients (R) and b (SE b).
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discrepancies in lipoprotein profiles of patients and con-
trols were not clearly evident prior to the inclusion of
HDL and LDL particle characteristics in the analysis.
When taking these findings into account, it appears that
traditional lipids and apolipoproteins measurements
could not be sufficient for accurate and timely estimation
of atherogenic dyslipidemia for this category of patients.
The usefulness of advanced lipid testing could be particu-
larly true for sdLDL-C, sdLDL-apoB, sdLDL-C (%), and
sdLDL-apoB (%) measurement, which is a rather simple
and nonexpensive method [15].
Previous studies have underlined the deleterious effect
of a prolonged pretransplantation period on patients’ sur-
vival [20,21]. Our current results could provide additional
confirmation of these findings, implying a role of pre-
transplantation disease progress in adverse perturbations
of HDL particle distributions. Namely, the proportion of
large HDL 2b subclasses negatively correlated, while the
proportion of small-sized HDL 3a particles positively cor-
related with the duration of prior chronic kidney disease
(Table 3). Although HDL and its subclasses are generally
regarded as cardioprotective, numerous studies [22,23]
revealed a major rearrangement of HDL particle distribu-
tion in favor of smaller HDL subclasses in subjects with
CVD. In attempting to explain such findings, it has been
demonstrated that smaller HDL subclasses, even if they
are essentially protective, can be highly vulnerable to pos-
sible detrimental effects of dyslipidemia, enhanced oxida-
tive stress and inflammation [24]. Moreover, it has been
suggested that such adverse conditions in the vascular
environment could provoke certain impairments in the
structure of small HDL particles, which in turn might
decrease their anti-atherogenic capacity or even induce
pro-atherogenic properties [5]. It has been shown that
the uremic milieu affects HDL’s ability to protect LDL
from oxidation [25], its capacity for reverse cholesterol
transport [26] and anti-inflammatory properties [27]. On
the other hand, we found that renal transplant recipients
had higher TG levels (Table 2). In addition, HDL size
strongly inversely correlated with TG concentration, thus
confirming a central role of hypertriglyceridemia in the
formation of small-sized HDL particles. Our finding of
increased CETP activity (Table 2) could provide addi-
tional insight into observed changes in HDL subclass dis-
tribution of the patients. Namely, in the case of elevated
TG concentration, enhanced CETP activity mediates gen-
eration of smaller, TG-enriched HDL particles [24]. Based
on the above-mentioned findings, we could speculate that
previous uremia and later dyslipidemia, commonly seen
in renal transplant recipients, together contribute to
adverse modifications in the HDL particle profile, thereby
further increasing CVD risk.
Preceding observations are further strengthened by
strong positive association between small-sized HDL 3b
particles and cIMT (Table 4). In previous studies regarding
cIMT in pediatric renal transplant recipients [28,29], tradi-
tional lipid measurements were not recognized as indepen-
dent predictors of increased cIMT, in contrast to similar
studies in adults [30]. The authors [28,29] explained such
inconsistency with the fact that the investigated patients
were younger, with shorter duration of renal disease and
consequently, with shorter exposure to hyperlipidemia.
Similarly to Mitsefnes et al. [28], we found that systolic
blood pressure was independently associated with cIMT.
Further inclusion of measured LDL and HDL characteris-
tics in the analysis revealed the proportion of small HDL
3b particles as another independent covariate. Obtained
results suggest a role of lipid abnormalities in the develop-
ment of arterial wall thickness in pediatric renal transplant
Figure 3 Concentrations of sdLDL-C and sdLDL-apoB in renal trans-
plant recipients according to immunosuppressive therapy. Lower and
upper lines indicate the 10th and 90th percentiles. The box indicates the
25th and 75th percentiles, while the line in the box indicates the median
value. sdLDL-C, small, dense low-density lipoprotein-cholesterol;
sdLDL-apoB, small, dense low-density lipoprotein-apolipoprotein B.
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recipients, although such association might not be evident
with regard to traditional lipid parameters.
Among CVD risk factors specific for transplantation,
immunosuppression plays an important role. For this rea-
son, we investigated the influence of different immuno-
suppressant drugs on HDL and LDL particle
characteristics. A shift toward smaller, more atherogenic
HDL and LDL particles was observed in patients who
were treated with cyclosporine when compared with sub-
jects treated with tacrolimus. However, statistical signifi-
cance was reached only in the case of sdLDL-C and
sdLDL-apoB (Fig. 3). It has been already shown that the
conversion from cyclosporine to tacrolimus results in
reduced serum LDL-C levels [10]. In addition, in the
study by Apanay et al. [31], patients treated with higher
cyclosporine levels showed significantly higher LDL oxida-
tion susceptibility when compared with controls. In con-
trast, Cofan et al. [32] noted that tacrolimus therapy
resulted in a LDL oxidation profile similar to that in
healthy controls. Taking all together, we could conclude
that conversion from cyclosporine to tacrolimus might
have beneficial effects on both LDL particles distribution
and susceptibility to oxidation, thereby reducing LDL’s
atherogenic potential. In contrast, we did not find signifi-
cant differences in HDL size and subclasses profile
between patients who received cyclosporine and those
treated with tacrolimus. In a recent study, Seymen et al.
[33] showed that switching from cyclosporine to tacroli-
mus may improve dyslipidemia by decreasing all serum
lipid and lipoprotein concentrations. However, in the
same study [33] the authors reported that tacrolimus
administration had no effect on serum HDL 2/HDL 3
levels, which is in line with our current results.
There are some limitations to this study. First, cIMT
measurement was not performed in the control group.
Ideally, this study would have been better controlled by
measuring cIMT in healthy children. However, this is not
a common screening procedure at annual medical check-
ups. The main objective of this study was to evaluate
LDL and HDL particle characteristics in pediatric renal
transplant recipients, which may account for increased
cIMT as a part of their presumed higher CVD risk. The
reason for including the control group was to show that
even with a small group of healthy children, LDL and
HDL particle distributions are worse in pediatric renal
transplant recipients. Another limitation is that, because
of the cross-sectional design of the study, we could not
prove a causal relationship between smaller HDL sub-
classes and higher cIMT values. However, this study may
offer some basic observations that could form the basis
for future in-depth studies.
In conclusion, our results demonstrated altered HDL
and LDL particles characteristics, with a shift toward
smaller, more atherogenic subfractions in pediatric renal
transplant recipients. In addition, according to our data,
alterations in the relative proportion of small-sized HDL
3b particles might influence cIMT. Finally, the results pre-
sented herein suggest the potential benefit of advanced
lipid testing for monitoring risk of lipid abnormalities
and planning therapy with the aim to improve patient’s
survival and quality of life.
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